Elena Generali
Overview
Explore the profile of Elena Generali including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
565
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cacciapaglia F, De Angelis R, Ferri C, Bajocchi G, Bellando-Randone S, Bruni C, et al.
J Rheumatol
. 2025 Jan;
PMID: 39814435
Objective: Bosentan (BOS) is approved for treating pulmonary arterial hypertension (PAH) and preventing digital ulcers (DU) in systemic sclerosis (SSc). Our study aimed to evaluate whether BOS prescribed for DU...
2.
Cento V, Carloni S, Sarti R, Bussini L, Asif Z, Morelli P, et al.
J Glob Antimicrob Resist
. 2025 Jan;
41:202-210.
PMID: 39805348
Objective: This study aimed to investigate the microbiological and clinical heterogeneity of community-onset bloodstream infections (BSIs) and identify features to support targeted empirical antibiotic therapy in the Emergency Department (ED)....
3.
Shiffer D, Desai A, Cesari M, Generali E, Greco M, Savioli G, et al.
Geroscience
. 2025 Jan;
PMID: 39804559
As the elderly population expands, enhancing emergency department (ED) care by assessing frailty becomes increasingly vital. To address this, we developed a novel electronic Frailty Index (eFI) from ED health...
4.
Generali E, Aliberti S, Cecconi M, Voza A
Arch Bronconeumol
. 2024 Dec;
61(3):125-126.
PMID: 39648117
No abstract available.
5.
Desai A, Shiffer D, Giordano M, Lucifero A, Generali E, Reggiani F, et al.
Life (Basel)
. 2024 Mar;
14(3).
PMID: 38541634
Background: Traumatic brain injury (TBI) in the elderly is a noteworthy pathology due to the exponential increase in population age, and the effects of antiplatelet and anticoagulation on patients' outcomes...
6.
Riccieri V, Pellegrino G, Cipolletta E, Giuggioli D, Bajocchi G, Bellando-Randone S, et al.
J Scleroderma Relat Disord
. 2024 Feb;
9(1):38-49.
PMID: 38333531
Background: Intravenous iloprost has been widely used for the treatment of systemic sclerosis peripheral vasculopathy. No agreement has been found on the regimen and the dosage of intravenous iloprost in...
7.
De Angelis R, Ferri C, Giuggioli D, Bajocchi G, Dagna L, Bellando-Randone S, et al.
RMD Open
. 2023 Mar;
9(1).
PMID: 36868782
Objective: To describe demographic, clinical and laboratory features of systemic sclerosis sine scleroderma (ssSSc) in a large multicentre systemic sclerosis (SSc) cohort. Methods: Data involving 1808 SSc patients from Italian...
8.
Genovesi S, Regolisti G, Rebora P, Occhino G, Belli M, Molon G, et al.
J Nephrol
. 2022 Aug;
36(3):621-626.
PMID: 36001295
Background: The prognostic impact of electrolyte disorders in hospitalized COVID-19 patients is unclear. Methods: The study included all adult patients hospitalized for COVID-19 in four hospitals in Northern Italy between...
9.
Ferri C, De Angelis R, Giuggioli D, Bajocchi G, Dagna L, Zanframundo G, et al.
Autoimmun Rev
. 2022 Jul;
21(10):103159.
PMID: 35908642
Introduction: Systemic sclerosis (SSc) is characterized by a complex etiopathogenesis encompassing both host genetic and environmental -infectious/toxic- factors responsible for altered fibrogenesis and diffuse microangiopathy. A wide spectrum of clinical...
10.
Ferri C, Raimondo V, Gragnani L, Giuggioli D, Dagna L, Tavoni A, et al.
Curr Pharm Des
. 2022 Jun;
28(24):2022-2028.
PMID: 35726427
Objective: Autoimmune systemic diseases (ASD) represent a predisposing condition to COVID-19. Our prospective, observational multicenter telephone survey study aimed to investigate the prevalence, prognostic factors, and outcomes of COVID-19 in...